Added to YB: 2025-08-07
Pitch date: 2025-06-20
TOI [bullish]
Starling Oncology, Inc.
+178.3%
current return
Author Info
No bio for this author
Company Info
Starling Oncology, Inc., an oncology company, provides various oncology services in the United States.
Market Cap
$638.0M
Pitch Price
$2.35
Price Target
6.40 (-4%)
Dividend
N/A
EV/EBITDA
-77.56
P/E
-20.58
EV/Sales
1.19
Sector
Health Care Providers and Services
Category
growth
The Oncology Institute, Inc. - $TOI
TOI: Oncology value-based care platform at inflection point. Cancer market growing fast (aging, new treatments) while TOI offers 30%+ lower costs vs hospitals. $3 PMPM in CA vs $30+ in FL. 2025 gross profit +40% YoY with EBITDA positive by Q4. OneOncology sold at 19x EBITDA; 17x 2027E EBITDA = 3x return. PT $6.40 (0.5x rev for 20%+ growth).
Read full article (10 min)